<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN"
                      "http://www.w3.org/TR/REC-html40/loose.dtd">
<HTML>
<HEAD>
<TITLE>extropians: Re: Telomeres and stuff</TITLE>
<META NAME="Author" CONTENT="Brian Manning Delaney (bdelaney@infinitefaculty.com)">
<META NAME="Subject" CONTENT="Re: Telomeres and stuff">
</HEAD>
<BODY BGCOLOR="#FFFFFF" TEXT="#000000">
<H1>Re: Telomeres and stuff</H1>
<!-- received="Mon May  1 19:38:18 2000" -->
<!-- isoreceived="20000502013818" -->
<!-- sent="Mon, 01 May 2000 11:17:05 -0700" -->
<!-- isosent="20000501181705" -->
<!-- name="Brian Manning Delaney" -->
<!-- email="bdelaney@infinitefaculty.com" -->
<!-- subject="Re: Telomeres and stuff" -->
<!-- id="390DCA21.EF6FE891@infinitefaculty.com" -->
<!-- inreplyto="ce.4c2e7a7.263f0e35@aol.com" -->
<STRONG>From:</STRONG> Brian Manning Delaney (<A HREF="mailto:bdelaney@infinitefaculty.com?Subject=Re:%20Telomeres%20and%20stuff&In-Reply-To=&lt;390DCA21.EF6FE891@infinitefaculty.com&gt;"><EM>bdelaney@infinitefaculty.com</EM></A>)<BR>
<STRONG>Date:</STRONG> Mon May 01 2000 - 12:17:05 MDT
<P>
<!-- next="start" -->
<UL>
<LI><STRONG>Next message:</STRONG> <A HREF="2024.html">Emlyn (pentacle): "Re: Pol: Reaction to Microsoft Ruling"</A>
<LI><STRONG>Previous message:</STRONG> <A HREF="2022.html">Michael S. Lorrey: "Re: Working Within the System"</A>
<LI><STRONG>In reply to:</STRONG> <A HREF="1966.html">CurtAdams@aol.com: "Re: Telomeres and stuff"</A>
<!-- nextthread="start" -->
<LI><STRONG>Next in thread:</STRONG> <A HREF="2037.html">John Clark: "Re: Telomeres and stuff"</A>
<!-- reply="end" -->
<LI><STRONG>Messages sorted by:</STRONG> 
<A HREF="date.html#2023">[ date ]</A>
<A HREF="index.html#2023">[ thread ]</A>
<A HREF="subject.html#2023">[ subject ]</A>
<A HREF="author.html#2023">[ author ]</A>
</UL>
<HR NOSHADE><P>
<!-- body="start" -->
<P>
<A HREF="mailto:CurtAdams@aol.com?Subject=Re:%20Telomeres%20and%20stuff&In-Reply-To=&lt;390DCA21.EF6FE891@infinitefaculty.com&gt;">CurtAdams@aol.com</A> wrote:
<BR>
<EM> &gt;
</EM><BR>
<EM> &gt; In a message dated 5/1/00 7:14:07 AM Pacific Daylight Time,
</EM><BR>
<EM> &gt; <A HREF="mailto:jonkc@worldnet.att.net?Subject=Re:%20Telomeres%20and%20stuff&In-Reply-To=&lt;390DCA21.EF6FE891@infinitefaculty.com&gt;">jonkc@worldnet.att.net</A> writes:
</EM><BR>
<P><EM> &gt;&gt; And it's been known since the 60's that
</EM><BR>
<EM> &gt;&gt; cells from old animals put in a tissue culture
</EM><BR>
<EM> &gt;&gt; divide less than that of
</EM><BR>
<EM> &gt;&gt; younger ones from the same species,
</EM><BR>
<EM> &gt;
</EM><BR>
<EM> &gt; Actually there are studies on both sides of that;
</EM><BR>
<EM> &gt; just recently I saw a mention
</EM><BR>
<EM> &gt; of some study that &quot;conclusively proved&quot; old human
</EM><BR>
<EM> &gt; cells do not divide less than cells from young
</EM><BR>
<EM> &gt; adults (so obviously the issue is still open). Fetal
</EM><BR>
<EM> &gt; cells *do* outlast adult cells; but that may be
</EM><BR>
<EM> &gt; a different process.
</EM><BR>
<P>Hi Curt,
<BR>
<P>Are you by (very small) chance thinking of Aubrey de Grey's response to my post
<BR>
in Sci.life-extension?
<BR>
<P>de Grey wrote:
<BR>
<EM> &gt; [...] the most recent and most thorough work
</EM><BR>
<EM> &gt; (Cristofalo et al, PNAS 95:10614) suggests
</EM><BR>
<EM> &gt; that telomeres do not shorten at all in the
</EM><BR>
<EM> &gt; cell type most commonly used for cell senescence
</EM><BR>
<EM> &gt; studies in vitro (dermal fibroblasts), [....]
</EM><BR>
<P>That was news to me (though I'm not up to speed on this research at all).
<BR>
<P>Of course, all scientists make mistakes (Ames, for ex. :), so I need to look at
<BR>
the study before being certain.
<BR>
<P>Have you read it, or, if this isn't the study you saw mentioned: any details
<BR>
about any other relevant study?
<BR>
<P>This is an extremely exciting area of research. (It will be fascinating, from a
<BR>
political/sociological standpoint, to see what happens when, in a very small
<BR>
number of years [zero, some are now saying...], the means to greatly extended
<BR>
life span are clearly at our disposal, but the standard medical research
<BR>
protocol -- clinical trials, etc. -- hasn't yet run its multi-year course, and
<BR>
people with a lot of extra cash start thinking, &quot;Hey, I can just buy the
<BR>
necessary lab equipment, hire a couple of underpaid bio-med researchers, and a
<BR>
doc, and....&quot; It will be legal somewhere in the world quickly, though,
<BR>
presumably. But who knows.)
<BR>
<P>Thanks,
<BR>
Brian.
<BR>
<P><!-- body="end" -->
<HR NOSHADE>
<UL>
<!-- next="start" -->
<LI><STRONG>Next message:</STRONG> <A HREF="2024.html">Emlyn (pentacle): "Re: Pol: Reaction to Microsoft Ruling"</A>
<LI><STRONG>Previous message:</STRONG> <A HREF="2022.html">Michael S. Lorrey: "Re: Working Within the System"</A>
<LI><STRONG>In reply to:</STRONG> <A HREF="1966.html">CurtAdams@aol.com: "Re: Telomeres and stuff"</A>
<!-- nextthread="start" -->
<LI><STRONG>Next in thread:</STRONG> <A HREF="2037.html">John Clark: "Re: Telomeres and stuff"</A>
<!-- reply="end" -->
<LI><STRONG>Messages sorted by:</STRONG> 
<A HREF="date.html#2023">[ date ]</A>
<A HREF="index.html#2023">[ thread ]</A>
<A HREF="subject.html#2023">[ subject ]</A>
<A HREF="author.html#2023">[ author ]</A>
</UL>
<!-- trailer="footer" -->
<HR NOSHADE>
<P>
<SMALL>
<EM>
This archive was generated by <A HREF="http://www.hypermail.org/">hypermail 2b29</A> 
: <EM>Thu Jul 27 2000 - 14:10:07 MDT</EM>
</EM>
</SMALL>
</BODY>
</HTML>
